Addressing the medicines access challenge through balance, evidence, collaboration and transparency: key take-away lessons of the 4th PPRI Conference

Sabine Vogler*, Nina Zimmermann, Zaheer Ud Din Babar, Reinhard Busse, Jaime Espin, Aukje K. Mantel-Teeuwisse, Dimitra Panteli, Fatima Suleman, Veronika J. Wirtz

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Abstract

The 4th PPRI Conference, held in Vienna in October 2019, addressed issues related to equitable and affordable access to medicines. A multi-stakeholder audience from around the globe discussed solutions and best practice models for current challenges such as high-priced medicines, limitations of current pricing and reimbursement policies and tight budgets for health technologies. A multi-faceted approach (so-called balance, evidence, collaboration and transparency/BECT strategy) was also discussed. This includes an improved balance of different interests and policy areas, generation of relevant evidence, collaboration between countries and stakeholders, and transparency, and was considered as the most promising pathway for the future.

Original languageEnglish
Article number18
Pages (from-to)1-5
JournalJournal of Pharmaceutical Policy and Practice
Volume14
Issue number1
DOIs
Publication statusPublished - 25 Jan 2021

Keywords

  • Access to medicines
  • Affordability
  • Collaboration
  • Debate
  • Medicine prices
  • Policy options
  • Pricing policies
  • Reimbursement

Fingerprint

Dive into the research topics of 'Addressing the medicines access challenge through balance, evidence, collaboration and transparency: key take-away lessons of the 4th PPRI Conference'. Together they form a unique fingerprint.

Cite this